Health Condition 1: null- Cancer patients
Conditions
Interventions
None listed
Sponsors
Epigeneres Biotech Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cancer group - Have a type of cancer disease. 2. Healthy group - who are not on any regular medication. 3. Are aged 21 years or older. 4. Are willing to consent to the storage of specimens for future research. 5. Subjects enrolled will be able to provide informed consent for themselves.
Exclusion criteria
Exclusion criteria: 1. Are incarcerated. 2 Are unwilling or unable to comply with prescribed therapy. 3. Subjects that lack the capacity to provide informed consent autonomously are to be excluded. 4. Pregnant or lactating women. 5. Subjects who have participated in any clinical trial in the past 1 month. 6. Any other condition that in the opinion of the investigator that does not justify the subjectâ??s participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expression profile of the molecular immuno- markers will help in analyzing the probability of manifestation of cancer, before any clinical symptoms begin to appear in healthy individuals and the development of the disease in cancer patients.Timepoint: 0 days | — |
Secondary
| Measure | Time frame |
|---|---|
| The expression profile of the molecular immuno- markers will help in understanding the efficacious treatment for the cancer patientTimepoint: 0 days | — |
Countries
India
Contacts
Public ContactDr Astrid Velho
Spectrum healthcare
Outcome results
None listed